Olivier Hanon < Olivier Rascol < Olivier Vanderhaeghe

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 26.
[20-40] [0 - 20][0 - 26]

Ident.	Authors (with country if any)	Title
000232 (2007)	Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada]	Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa
000233 (2007)	Christopher G. Goetz [États-Unis] ; Stanley Fahn [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Matthew B. Stern [États-Unis] ; Barbara C. Tilley [États-Unis] ; Richard Dodel [Allemagne] ; Bruno Dubois [France] ; Robert Holloway [États-Unis] ; Joseph Jankovic [États-Unis] ; Jaime Kulisevsky [Espagne] ; Anthony E. Lang [Canada] ; Andrew Lees [Royaume-Uni] ; Sue Leurgans [États-Unis] ; Peter A. Lewitt [États-Unis] ; David Nyenhuis [États-Unis] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Anette Schrag [Royaume-Uni] ; Jeanne A. Teresi [États-Unis] ; Jacobus J. Van Hilten [Pays-Bas] ; Nancy Lapelle [États-Unis]	Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan
000245 (2006)	Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni]	Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa
000263 (2004)	C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio [Portugal] ; Fabrizio Stocchi [Italie]	Levodopa in the treatment of Parkinson's disease: Current controversies
000275 (2003)	Alan L. Whone [Royaume-Uni] ; Ray L. Watts [États-Unis] ; A. Jon Stoessl [Canada] ; Margaret Davis [États-Unis] ; Sven Reske [Allemagne] ; Claude Nahmias ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Maria J. Ribeiro [France] ; Philippe Remy [France] ; Werner Poewe [Autriche] ; Robert A. Hauser [États-Unis] ; David J. Brooks [Royaume-Uni]	Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study
000293 (2001)	Olivier Rascol [France] ; Joaquim J. Ferreira [Portugal] ; Claire Thalamas [France] ; Monique Galitsky [France] ; Jean-Louis Montastruc [France]	Dopamine agonists: Their role in the management of Parkinson's disease

---

List of associated KwdEn.i

Nombre de documents	Descripteur
19	Parkinson disease
14	Nervous system diseases
13	Parkinson's disease
9	Treatment
8	Dopamine agonist
7	Levodopa
5	dyskinesia
5	levodopa
4	Dyskinesia
4	Human
4	Humans
4	Parkinson Disease (drug therapy)
3	Double blind study
3	Ropinirole
3	clinimetrics
3	dopamine agonists
3	rating scales
2	Amine oxidase (flavin-containing)
2	Animals
2	Antiparkinson Agents (therapeutic use)
2	Antiparkinson agent
2	Clinical trial
2	Deep brain stimulation
2	Evaluation scale
2	Evidence-based medicine
2	Motor system disorder
2	Myelodysplastic syndrome
2	Pardoprunox
2	Partial agonist
2	Placebo
2	Rasagiline
2	Revision
2	deep brain stimulation
2	evidence‐based medicine
2	motor complications
2	partial dopamine agonist
2	ropinirole
2	treatment
1	AMPA receptor
1	AMPA receptor antagonist
1	Accidental Falls (statistics & numerical data)
1	Acupuncture
1	Acupuncture Therapy
1	Adult
1	Aged
1	Aged, 80 and over
1	Agonist
1	Amantadine
1	Aminoacid
1	Antiparkinson Agents (adverse effects)
1	Antiparkinson Agents (classification)
1	Antipsychotic Agents (administration & dosage)
1	Antipsychotic Agents (adverse effects)
1	Bibliographic review
1	Carbidopa
1	Cardiovascular disease
1	Cartography
1	Catecholamine
1	Chemotherapy
1	Clinical Trials as Topic (methods)
1	Clinical management
1	Clozapine
1	Comparative study
1	Complication
1	D2 Dopamine receptor
1	Deep Brain Stimulation
1	Delay
1	Disease Models, Animal
1	Dopa
1	Dopamine
1	Drug
1	Drug Evaluation, Preclinical
1	Drug Therapy, Combination
1	Dyskinesias (drug therapy)
1	Edema (epidemiology)
1	Emission tomography
1	Entacapone
1	Evidence-Based Medicine
1	Female
1	Fetal Stem Cells (transplantation)
1	Fluctuations
1	Force
1	Glutamate
1	Heart failure
1	Hemostatic
1	Hypotension, Orthostatic (epidemiology)
1	Infection (epidemiology)
1	Levodopa (adverse effects)
1	Male
1	Medicine
1	Middle Aged
1	Modification
1	Motor Activity
1	Motor control
1	Naftazone
1	Neuroprotective Agents (therapeutic use)
1	Neuroprotective agent
1	Pallidotomy
1	Parkinson Disease (complications)
1	Parkinson Disease (mortality)

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Olivier Rascol" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Olivier Rascol" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Olivier Rascol
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022